A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma

Clinical trial NCT01030783 · COMPLETED

Trial details

NCT number: NCT01030783
Sponsor: AVEO Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Renal Cell Carcinoma

Start date: 2009-12-01
Primary completion: 2012-07-01
Enrollment: 517

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.